310 related articles for article (PubMed ID: 21478911)
41. Lycorine induces cell death in MM by suppressing Janus Kinase/signal transducer and activator of transcription via inducing the expression of SOCS1.
Jin Z; Zhou S; Zhang Y; Ye H; Jiang S; Yu K; Ma Y
Biomed Pharmacother; 2016 Dec; 84():1645-1653. PubMed ID: 27847203
[TBL] [Abstract][Full Text] [Related]
42. TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway.
Quy LN; Choi YW; Kim YH; Chwae YJ; Park TJ; Lim IK
Cell Signal; 2013 Dec; 25(12):2391-9. PubMed ID: 23917204
[TBL] [Abstract][Full Text] [Related]
43. The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications.
Ogiya D; Liu J; Ohguchi H; Kurata K; Samur MK; Tai YT; Adamia S; Ando K; Hideshima T; Anderson KC
Blood; 2020 Nov; 136(20):2334-2345. PubMed ID: 32844992
[TBL] [Abstract][Full Text] [Related]
44. Serum- and glucocorticoid-regulated kinase 1 (SGK1) induction by the EWS/NOR1(NR4A3) fusion protein.
Poulin H; Filion C; Ladanyi M; Labelle Y
Biochem Biophys Res Commun; 2006 Jul; 346(1):306-13. PubMed ID: 16756948
[TBL] [Abstract][Full Text] [Related]
45. Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell lines.
Hausmann S; Brandt E; Köchel C; Einsele H; Bargou RC; Seggewiss-Bernhardt R; Stühmer T
PLoS One; 2015; 10(4):e0122689. PubMed ID: 25837824
[TBL] [Abstract][Full Text] [Related]
46. Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.
Bar-Natan M; Stroopinsky D; Luptakova K; Coll MD; Apel A; Rajabi H; Pyzer AR; Palmer K; Reagan MR; Nahas MR; Karp Leaf R; Jain S; Arnason J; Ghobrial IM; Anderson KC; Kufe D; Rosenblatt J; Avigan D
Br J Haematol; 2017 Mar; 176(6):929-938. PubMed ID: 28107546
[TBL] [Abstract][Full Text] [Related]
47. Increased expression and activation of serum- and glucocorticoid-inducible kinase-1 (SGK1) by cadmium in HK-2 renal proximal tubular epithelial cells.
Miyayama T; Matsuoka M
Environ Toxicol Pharmacol; 2014 Sep; 38(2):374-8. PubMed ID: 25128767
[TBL] [Abstract][Full Text] [Related]
48. HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.
Borsi E; Perrone G; Terragna C; Martello M; Zamagni E; Tacchetti P; Pantani L; Brioli A; Dico AF; Zannetti BA; Rocchi S; Cavo M
Exp Cell Res; 2014 Nov; 328(2):444-55. PubMed ID: 25257607
[TBL] [Abstract][Full Text] [Related]
49. Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
Schmid E; Stagno MJ; Yan J; Schleicher S; Yu W; Honisch S; Lang F; Fuchs J; Seitz G
Cell Physiol Biochem; 2017; 43(3):1301-1308. PubMed ID: 28992614
[TBL] [Abstract][Full Text] [Related]
50. Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.
Meads MB; Fang B; Mathews L; Gemmer J; Nong L; Rosado-Lopez I; Nguyen T; Ring JE; Matsui W; MacLeod AR; Pachter JA; Hazlehurst LA; Koomen JM; Shain KH
Oncogene; 2016 May; 35(21):2723-34. PubMed ID: 26387544
[TBL] [Abstract][Full Text] [Related]
51. Potential crosstalk of the interleukin-6-heme oxygenase-1-dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells.
Wu W; Ma D; Wang P; Cao L; Lu T; Fang Q; Zhao J; Wang J
FEBS J; 2016 Mar; 283(5):834-49. PubMed ID: 26700310
[TBL] [Abstract][Full Text] [Related]
52. Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line.
Verdelli D; Nobili L; Todoerti K; Mosca L; Fabris S; D'Anca M; Pellegrino E; Piva R; Inghirami G; Capelli C; Introna M; Baldini L; Chiaramonte R; Lombardi L; Neri A
Genes Chromosomes Cancer; 2014 Feb; 53(2):154-67. PubMed ID: 24327544
[TBL] [Abstract][Full Text] [Related]
53. Diverse effects of ANXA7 and p53 on LNCaP prostate cancer cells are associated with regulation of SGK1 transcription and phosphorylation of the SGK1 target FOXO3A.
Srivastava M; Leighton X; Starr J; Eidelman O; Pollard HB
Biomed Res Int; 2014; 2014():193635. PubMed ID: 24864229
[TBL] [Abstract][Full Text] [Related]
54. Sgk1 regulates desmoglein 1 expression levels in oligodendrocytes in the mouse corpus callosum after chronic stress exposure.
Miyata S; Yoshikawa K; Taniguchi M; Ishikawa T; Tanaka T; Shimizu S; Tohyama M
Biochem Biophys Res Commun; 2015 Aug; 464(1):76-82. PubMed ID: 26043694
[TBL] [Abstract][Full Text] [Related]
55. A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma.
Amet R; Previtali V; Mihigo HB; Sheridan E; Brophy S; Hante NK; Santos-Martinez MJ; Hayden PJ; Browne PV; Rozas I; McElligott AM; Zisterer DM
Life Sci; 2022 Feb; 290():120236. PubMed ID: 34953891
[TBL] [Abstract][Full Text] [Related]
56. Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma.
Liang P; Cheng SH; Cheng CK; Lau KM; Lin SY; Chow EY; Chan NP; Ip RK; Wong RS; Ng MH
Haematologica; 2013 Feb; 98(2):288-95. PubMed ID: 22929979
[TBL] [Abstract][Full Text] [Related]
57. Interleukin-21 is a growth and survival factor for human myeloma cells.
Brenne AT; Ro TB; Waage A; Sundan A; Borset M; Hjorth-Hansen H
Blood; 2002 May; 99(10):3756-62. PubMed ID: 11986233
[TBL] [Abstract][Full Text] [Related]
58. Effect of glucose deprivation on the expression of genes encoding glucocorticoid receptor and some related factors in ERN1-knockdown U87 glioma cells.
Riabovol OO; Tsymbal DO; Minchenko DO; Lebid-Biletska KM; Sliusar MY; Rudnytska OV; Minchenko OH
Endocr Regul; 2019 Oct; 53(4):237-249. PubMed ID: 31734653
[TBL] [Abstract][Full Text] [Related]
59. Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth.
Burger R; Günther A; Klausz K; Staudinger M; Peipp M; Penas EM; Rose-John S; Wijdenes J; Gramatzki M
Haematologica; 2017 Feb; 102(2):381-390. PubMed ID: 27658435
[TBL] [Abstract][Full Text] [Related]
60. Differential regulation of serum- and glucocorticoid-inducible kinase 1 (SGK1) splice variants based on alternative initiation of transcription.
Simon P; Schneck M; Hochstetter T; Koutsouki E; Mittelbronn M; Merseburger A; Weigert C; Niess A; Lang F
Cell Physiol Biochem; 2007; 20(6):715-28. PubMed ID: 17982254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
